Literature DB >> 15489895

Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays.

Noriyoshi Fukushima1, Norihiro Sato, Nijaguna Prasad, Steven D Leach, Ralph H Hruban, Michael Goggins.   

Abstract

Mucinous cystic neoplasms (MCNs) of the pancreas are uncommon neoplasms usually located in the body or tail of the pancreas and usually in females (>90% of cases). Clinically, they are often misdiagnosed as non-neoplastic pseudocysts leading to failed opportunities for curative resection. To better understand the biology of MCNs and to identify markers of the disease, we performed global gene expression profiling of MCNs using oligonucleotide microarrays. Using laser capture microdissection applied to frozen sections, RNA was extracted from the neoplastic epithelium of MCNs, from the adjacent 'ovarian-type' stroma of MCNs, from histologically normal pancreatic ductal epithelium, from pancreatic acinar tissue and from fibrous stroma in pancreata affected by chronic pancreatitis. Each RNA sample was subjected to two rounds of linear amplification followed by hybridization with U133A gene chips (Affymetrix). The expression patterns of selected genes were confirmed by quantitative RT-PCR and by immunohistochemistry using tissue microarrays containing 19 resected MCNs. A total of 114 known genes were overexpressed in the neoplastic epithelium compared to normal pancreatic ductal epithelium (>3-fold) including S100P, PSCA, c-myc, STK6/STK15, cathepsin E and pepsinogen C. Activation of the Notch pathway in the epithelial component of MCNs was evident by the demonstration of overexpression of Jagged1 and the downstream Notch pathway member Hes1. In the 'ovarian-type' stroma, several genes involved in estrogen metabolism were overexpressed including STAR and ESR1 genes. Some of the genes identified as overexpressed in these neoplasms may be useful as markers that can distinguish MCNs from non-neoplastic pancreatic cystic lesions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15489895     DOI: 10.1038/sj.onc.1208117

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

Review 1.  S100P: a novel therapeutic target for cancer.

Authors:  Thiruvengadam Arumugam; Craig D Logsdon
Journal:  Amino Acids       Date:  2010-05-28       Impact factor: 3.520

2.  Suppression of Aurora-A oncogenic potential by c-Myc downregulation.

Authors:  Shangbin Yang; Shun He; Xiaobo Zhou; Mei Liu; Hongxia Zhu; Yihua Wang; Wei Zhang; Shuang Yan; Lanping Quan; Jingfeng Bai; Ningzhi Xu
Journal:  Exp Mol Med       Date:  2010-11-30       Impact factor: 8.718

Review 3.  Identifying molecular markers for the early detection of pancreatic neoplasia.

Authors:  Michael Goggins
Journal:  Semin Oncol       Date:  2007-08       Impact factor: 4.929

4.  Identification of prognosis-related proteins in advanced gastric cancer by mass spectrometry-based comparative proteomics.

Authors:  Shu-Qin Jia; Zhao-Jian Niu; Lian-Hai Zhang; Xi-Yao Zhong; Tao Shi; Hong Du; Gui-Guo Zhang; Ying Hu; Xiu-Lan Su; Jia-Fu Ji
Journal:  J Cancer Res Clin Oncol       Date:  2008-10-01       Impact factor: 4.553

Review 5.  Insidious changes in stromal matrix fuel cancer progression.

Authors:  Fayth L Miles; Robert A Sikes
Journal:  Mol Cancer Res       Date:  2014-01-22       Impact factor: 5.852

6.  Molecular alterations in primary prostate cancer after androgen ablation therapy.

Authors:  Carolyn J M Best; John W Gillespie; Yajun Yi; Gadisetti V R Chandramouli; Mark A Perlmutter; Yvonne Gathright; Heidi S Erickson; Lauren Georgevich; Michael A Tangrea; Paul H Duray; Sergio González; Alfredo Velasco; W Marston Linehan; Robert J Matusik; Douglas K Price; William D Figg; Michael R Emmert-Buck; Rodrigo F Chuaqui
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

7.  Global Protease Activity Profiling Provides Differential Diagnosis of Pancreatic Cysts.

Authors:  Sam L Ivry; Jeremy M Sharib; Dana A Dominguez; Nilotpal Roy; Stacy E Hatcher; Michele T Yip-Schneider; C Max Schmidt; Randall E Brand; Walter G Park; Matthias Hebrok; Grace E Kim; Anthony J O'Donoghue; Kimberly S Kirkwood; Charles S Craik
Journal:  Clin Cancer Res       Date:  2017-04-19       Impact factor: 12.531

Review 8.  Insights into the Pathogenesis of Pancreatic Cystic Neoplasms.

Authors:  Vrishketan Sethi; Bhuwan Giri; Ashok Saluja; Vikas Dudeja
Journal:  Dig Dis Sci       Date:  2017-05-12       Impact factor: 3.199

Review 9.  The secret origins and surprising fates of pancreas tumors.

Authors:  Jennifer M Bailey; Kathleen E DelGiorno; Howard C Crawford
Journal:  Carcinogenesis       Date:  2014-02-28       Impact factor: 4.944

10.  Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.

Authors:  Kusumawadee Utispan; Peti Thuwajit; Yoshimitsu Abiko; Komgrid Charngkaew; Anucha Paupairoj; Siri Chau-in; Chanitra Thuwajit
Journal:  Mol Cancer       Date:  2010-01-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.